Cell line mixup causes retraction of paper on blood vessel damage

britjournnutWe’ve written before about retractions for cell lines that turn out not to be what researchers thought they were. In a few cases, that has involved contamination by HeLa cells, named for Henrietta Lacks. Today, we note the retraction of a paper whose authors, from Taiwan, thought they were using human muscle cells that line blood vessels when they were actually studying such cells from rat embryos.

Here’s the notice in the British Journal of Nutrition for “Molecular mechanism of green microalgae, Dunaliella salina, involved in attenuating balloon injury-induced neointimal formation”:

The article by Sheu et al. (1) has been retracted at the request of the authors. The cell lines were named as being human aortic smooth muscle cells (HASMCs). However, the authors have contacted us to state that these cells were in fact A10 cells from embryonic rats. Because of the fundamental nature of this error, the findings cannot be interpreted in the manner stated in the original article, and therefore this paper has been retracted. The authors apologise for this error.

For those wondering, Dunaliella salina is a green algae that lives in sea salt fields and produces high levels of beta-carotene. It is also sold by a neutraceutical company, which claims that “the benefits are endless.”

Here’s the original abstract of the paper:

The pathological mechanism of restenosis is primarily attributed to excessive proliferation of vascular smooth muscle cells (VSMC). The preventive effects of ethanol extract of Dunaliella salina (EDS) on balloon injury-induced neointimal formation were investigated. To explore its molecular mechanism in regulating cell proliferation, we first showed that EDS markedly reduced the human aortic smooth muscle cell proliferation via the inhibition of 5′-bromo-2′-deoxyuridine (BrdU) incorporation at 40 and 80 μg/ml. This was further supported by the G0/G1-phase arrest using a flow cytometric analysis. In an in vivo study, EDS at 40 and 80 μg/ml was previously administered to the Sprague–Dawley rats and found that the thickness of neointima, and the ratio of neointima:media were also reduced. EDS inhibited VSMC proliferation in a dose-dependent manner following stimulation of VSMC cultures with 15 % fetal bovine serum (FBS). Suppressed by EDS were 15 % FBS-stimulated intracellular Raf, phosphorylated extracellular signal-regulated kinases (p-Erk) involved in cell-cycle arrest and proliferating cell nuclear antigen. Phosphorylated focal adhesion kinase (p-FAK) was also suppressed by EDS. Also active caspase-9, caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) protein expression levels were increased by administration with EDS; the apoptotic pathway may play an important role in the regulatory effects of EDS on cell growth. These observations provide a mechanism of EDS in attenuating cell proliferation, thus as a potential intervention for restenosis.

The paper has been cited three times, including twice by the group that wrote it, according to Thomson Scientific’s Web of Knowledge.

2 thoughts on “Cell line mixup causes retraction of paper on blood vessel damage”

  1. I’m guessing A10 is also an immortalized cell line, vs the implication that they purchased primary culture. The paper merely says “Human aortic smooth muscle cells (HASMC) were purchased from the Food Industry Research and Development Institute, Hsinchu, Taiwan”. My guess is they purchased something like ATCC PCS-100-012, described as “Primary Aortic Smooth Muscle Cells”, which suggests the cells haven’t transformed to survive in the in vitro conditions of a culture dish.

    One A10 cell line paper (http://www.ncbi.nlm.nih.gov/pubmed/9415280) notes the following:

    “A10 cells expressed smooth muscle alpha-actin, SM22 alpha, smooth muscle calponin and vimentin, characteristic of in vivo rat VSMCs; however they also resembled de-differentiated smooth muscle cells in that they expressed non-muscle myosin rather than smooth muscle myosin heavy chain. A10 cells resembled cultured rat neonatal smooth muscle cells (“pup cells”) in that they had an epithelioid shape and lacked functional PDGF-alpha receptors”

    That said, I’m a little more concerned about the use of immortalized cell line where they imply use of a primary. I suppose they could purchase the correct human primary culture and repeat this…?

    1. Were the Cell Lines Authenticated at the start, middle and end of research? A lot of this could be avoided by having clear SOP’s in place to make sure you are dealing with the same cell line that is free of contamination. There will be a day that Cell Line Authentication is mandatory, as the research community has a solution to eliminate contamination, time, and money on trying to make great strides in cancer research.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.